{CurrentPage:PageName}

About Us

ACO Name and Location

Covenant ACO, Inc.
Previous Legal Business Entity Name: Covenant Health Partners, Inc.
3615 19th St
Lubbock, Texas 79410

ACO Primary Contact

Primary Contact Name

Nathan Taylor

Primary Contact Phone Number

Primary Contact Email Address

Organizational Information

ACO participants:

ACO Participants

ACO Participant in Joint Venture (Enter Y or N)

Lubbock Medical Associates

N

C. Michel Oliva, M.D. Pa

N

Womens Health Llp

N

Grace Clinic of Lubbock

N

Family First Healthcare Of Lubbock Llc

N

Justin McCarthy, MD, PA

N

West Texas Digestive Disease Center Pa

N

Ronnelle S Burley Pa

N

Lubbock Nephrology Associates, PA

N

Sergio Lara, MD, PA

N

Ear Nose and Throat Associates of Lubbock, PA

N

GEORGE C BAKATSAS

N

SWAT Surgical Associates, LLP

N

Kirk J Tiemann, MD, PA

N

Priscilla Snodgrass

N

Samuel Hale

N

CATHY MALOUF, M.D., PA

N

NEUROSURGERY ASSOCIATES OF LUBBOCK, LLP

N

James Gage

N

Lakhu Rohra

N

Family Foot And Ankle Care Pllc

N

ROBERT ORDONEZ

N

Lehman Dermatology Clinic, PA

N

FRANK M RYBURN III, M.D. P.A.

N

Lubbock Digestive Disease Associates

N

Lubbock Kidney Blood Pressure Clinic PA

N

METHODIST HOSPITAL LEVELLAND

N

Associates For Pain Management P.A.

N

Schwarzentraub Foot Clinic, PC

N

Elias Ghandour Pa

N

METHODIST HOSPITAL, PLAINVIEW, TEXAS

N

William A. Shaver, MD, PA

N

John E Streit Md Pa

N

James J Boop, MD, PA

N

Covenant Medical Group

N

West Texas Eye P A

N

Lubbock Dermatology

N

Lubbock Diagnostic Radiology, L.L.P.

N

LUBBOCK SURGICAL ASSOCIATES LLP

N

Arthritis & Osteoporosis Associates, LLP

N

Christopher R. Rose, MD, PA

N

PARATUS MEDICAL, INC

N

Lubbock Primary Care, PLLC

N

Owen Health Group, PLLC

N

Rodney T Franklin MD PA

N

MATTHEW P SOAPE MD PA

N

Susan Robertson Devine MD

N

ACO governing body:

Member

Member's Voting Power – Expressed as a percentage or number

Membership Type

ACO Participant Legal Business Name/DBA, if Applicable

Last Name

First Name

Title/Position

Rose

Christopher

Chair

0

ACO Participant Representative

Christopher R. Rose, MD, PA

Snodgrass

Brad

Vice Chair

1

ACO Participant Representative

Covenant Medical Group

Backlund

Amanda

Member

1

ACO Participant Representative

Covenant Medical Group

Blann

David

Member

1

ACO Participant Representative

Covenant Medical Group

Crossnoe

Chetlen

Member

1

ACO Participant Representative

Grace Clinic of Lubbock

Devine

Susan

Member

1

ACO Participant Representative

Susan Devine, MD

Dixon

Joseph

Member

1

ACO Participant Representative

Grace Clinic of Lubbock

Ferguson

Angela

Member

1

ACO Participant Representative

Covenant Medical Group

Fitz

Juan

Member

1

ACO Participant Representative

Covenant Medical Group

Gray

David

Member

1

ACO Participant Representative

Covenant Medical Group

Henderson

Richard

Member

1

ACO Participant Representative

Covenant Medical Group

Hensal

Frederick

Member

1

ACO Participant Representative

Covenant Medical Group

Kadiyala

Srinivas

Member

1

ACO Participant Representative

Covenant Medical Group

Kensing

Kelly

Member

1

ACO Participant Representative

Lubbock Digestive Disease Associates

Mangold

David

Member

1

ACO Participant Representative

Lubbock Surgical Associates, LLP

Nall

Brent

Member

1

ACO Participant Representative

Grace Clinic of Lubbock
Oakes David Member 1 ACO Participant Representative Covenant Medical Group
Patel Nilesh Member 1 ACO Participant Representative Covenant Medical Group
Rohra Lakhu Member 1 ACO Participant Representative Lakhu J. Rohra, MD
Rozean Randy Member 1 ACO Participant Representative

Family First HealthCare

Soriano

Karen

Member 1 ACO Participant Representative Covenant Medical Group
Wilks Brenda Member 1 Medicare Beneficiary Representative N/A

Key ACO clinical and administrative leadership:

Michael Robertson, MD

ACO Executive

Michael Robertson, MD

Medical Director

Nathan Taylor

Compliance Officer

Lisa Barrington

Quality Assurance/Improvement Officer

Associated committees and committee leadership:

Committee Name

Committee Leader Name and Position

Credentials Committee

Dr. Kelly Kensing, Chair

Population Health Committee

Dr. Nilesh Patel, Chair

Quality & Performance Committee

Dr. Frederick Hensal, Chair

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Networks of individual practices of ACO professionals
  • Partnerships or joint venture arrangements between hospitals and ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Second Agreement Period
    • Performance Year 2018, $2,415,533
    • Performance Year 2017, $282, 266
  • First Agreement Period
    • Performance Year 2016, $2,659,327
    • Performance Year 2015, $0
    • Performance Year 2014, $2,542,945

Shared Savings Distribution

  • Second Agreement Period
    • Performance Year 2018
      • Proportion invested in infastructure: 17%
      • Proportion invested in redesigned care processes/resources: 35%
      • Proportion of distribution to ACO participants: 48%
    • Performance Year 2017
      • Proportion invested in infastructure: 25%
      • Proportion invested in redesigned care processes/resources: 8%
      • Proportion of distribution to ACO participants: 66%
  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: 25%
      • Proportion invested in redesigned care processes/resources: 8%
      • Proportion of distribution to ACO participants: 66%
    • Performance Year 2015
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2014
      • Proportion invested in infrastructure: 25%
      • Proportion invested in redesigned care processes/resources: 25%
      • Proportion of distribution to ACO participants: 50%

Quality Performance Results

2018 Quality Performance Results:

ACO#

Measure Name

Rate

ACO Mean

ACO-1

CAHPS: Getting Timely Care, Appointments, and Information

89.70

86.14

ACO-2

CAHPS: How Well Your Providers Communicate

93.61

93.93

ACO-3

CAHPS: Patients’ Rating of Provider

93.57

92.45

ACO-4

CAHPS: Access to Specialists

84.71

81.50

ACO-5

CAHPS: Health Promotion and Education

54.98

59.26

ACO-6

CAHPS: Shared Decision Making

59.83

61.94

ACO-7

CAHPS: Health Status/Functional Status

70.04

73.35

ACO-34

CAHPS: Stewardship of Patient Resources

25.62

26.26

ACO-8

Risk Standardized, All Condition Readmission

14.15

14.98

ACO-35

Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)

19.02

18.59

ACO-36

All-Cause Unplanned Admissions for Patients with Diabetes

34.97

37.01

ACO-37

All-Cause Unplanned Admissions for Patients with Heart Failure

69.87

76.75

ACO-38

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

54.08

59.00

ACO-43

Ambulatory Sensitive Condition Acute Composite (AHRQ Prevention Quality Indicator (PQI) #91)

1.72

1.98

ACO-11

Use of Certified EHR Technology

96.52

98.20

ACO-12

Medication Reconciliation Post-Discharge

88.24

85.91

ACO-13

Falls: Screening for Future Fall Risk

74.43

79.73

ACO-44

Use of Imaging Studies for Low Back Pain

57.89

64.36

ACO-14

Preventive Care and Screening: Influenza Immunization

77.83

72.71

ACO-15

Pneumonia Vaccination Status for Older Adults

75.85

75.97

ACO-16

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up

88.43

76.83

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

93.10

72.81

ACO-18

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

60.63

66.74

ACO-19

Colorectal Cancer Screening

70.40

68.27

ACO-20

Breast Cancer Screening

72.54

71.96

ACO-42

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

82.22

81.47

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control

16.41

15.51

ACO-41

Diabetes: Eye Exam

69.92

52.42

ACO-28

Hypertension (HTN): Controlling High Blood Pressure

66.48

73.10

ACO-30

Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet

90.91

88.92

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

Payment Rule Waivers

  • Yes, our ACO does use the SNF 3-Day Rule Waiver, pursuant to 42 CFR 425.612.
  • Yes, our ACO clinicians do provide telehealth services using the flexibilities under 42 CFR 425.612(f) and 42 CFR 425.613.

Join Covenant Health Partners

Click Here
Join Covenant Health Partners